What they were paid
Vor Biopharma Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $13,283 | — | $91,925 | — | $105,208 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vor Biopharma Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-181883, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Vor Biopharma pays directors a $40,000 cash retainer.
The rest of the Vor Biopharma board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alexander (Bo) Cumbo | Independent Director | $121,365 |
| Andrew Levin | Independent Director | $31,881 |
| Daniella Beckman | Independent Director | $64,200 |
| Erez Kalir | Independent Director | $123,033 |
| Fouad Namouni | Independent Director | $51,089 |
| Jean-Paul Kress | Chair of the Board | $0 |
| Michel Detheux | Independent Director | $119,350 |
| Wouter Joustra | Independent Director | $31,881 |
The full Vor Biopharma compensation record
free company briefThis page is one director within Vor Biopharma's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat